Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics
- PMID: 10853876
- DOI: 10.1007/s002280050718
Comparison of several approaches of therapeutic drug monitoring of cyclosporin A based on individual pharmacokinetics
Abstract
Objective: The clinical outcome of patients after organ transplantation is correlated with cyclosporin A (CyA) exposure. It is generally accepted that the area under the concentration-time curve (AUC) provides a reliable means for drug exposure. However, in routine therapeutic drug monitoring (TDM) of CyA, trough levels are mostly used. Currently, a number of different new concepts of CyA-TDM, including approaches such as single, double or triple time-point and abbreviated AUC determinations, have been introduced. The purpose of this study was to compare the predictive value of the different strategies of TDM.
Methods: Calculations were based on 40 individual concentration time profiles after oral administration of CyA to patients who had been included into an ongoing prospective clinical trial. Non-compartmental analysis was used to calculate the AUC0-12h. Multiple linear regression was performed to describe the relationship between the different sets of blood concentrations and the respective AUC0-12h as well as to evaluate their predictive value regarding AUC. Predictive performance was assessed by prediction bias and prediction precision, which were estimated as the mean prediction error and root mean squared error, respectively.
Results: When comparing the various combinations of time points, it was found that one-point approaches showed the strongest differences with regard to the predictive value; the associated r2 values differed from 0.203 to 0.792. The two and three time-point approaches showed lower differences - r2 0.802-0.972. The four-point and five-point approaches (r2 0.942-0.982) were the strongest predictors for CyA AUC0-12h. Relative bias ranged from -27.7% to 63.8% and changed significantly when multiple-point predictors were used. In those cases, the predictive performance improved. Considering the predictive performance as well as the smallest bias and highest prediction precision, C3, C1 + C3, C1 + C3 + C6 and C1 + C2 + C3 + C6 were the best predictors.
Conclusion: The results of this study indicate that in kidney transplant patients a clinically sufficient precise estimation of the CyA AUC is possible using two or three concentration time points.
Similar articles
-
[Efficacy of therapeutic monitoring of cyclosporine through C2 and AUC(0-4) during the first 24 months following kidney transplantation].Vojnosanit Pregl. 2008 Feb;65(2):119-27. doi: 10.2298/vsp0802119v. Vojnosanit Pregl. 2008. PMID: 18365668 Serbian.
-
Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.Ther Drug Monit. 1998 Jun;20(3):276-83. doi: 10.1097/00007691-199806000-00007. Ther Drug Monit. 1998. PMID: 9631924
-
Evolution of the therapeutic drug monitoring of cyclosporine.Transplant Proc. 2004 Mar;36(2 Suppl):420S-425S. doi: 10.1016/j.transproceed.2004.01.054. Transplant Proc. 2004. PMID: 15041378 Review.
-
Therapeutic drug monitoring of cyclosporine and area under the curve prediction using a single time point strategy: appraisal using peak concentration data.Biopharm Drug Dispos. 2015 Dec;36(9):575-86. doi: 10.1002/bdd.1967. Epub 2015 Aug 20. Biopharm Drug Dispos. 2015. PMID: 26224332
-
Limited sampling strategies for estimating cyclosporin area under the concentration-time curve: review of current algorithms.Ther Drug Monit. 2001 Apr;23(2):100-14. doi: 10.1097/00007691-200104000-00003. Ther Drug Monit. 2001. PMID: 11294509 Review.
Cited by
-
Population pharmacokinetics of cyclosporine A in Japanese renal transplant patients: comprehensive analysis in a single center.Eur J Clin Pharmacol. 2017 Sep;73(9):1111-1119. doi: 10.1007/s00228-017-2279-2. Epub 2017 Jun 15. Eur J Clin Pharmacol. 2017. PMID: 28620753
-
Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy.Br J Clin Pharmacol. 2012 Apr;73(4):553-63. doi: 10.1111/j.1365-2125.2011.04116.x. Br J Clin Pharmacol. 2012. PMID: 21988410 Free PMC article.
-
Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC(0-12) monitoring in cardiac transplant recipients over the first year post-transplantation.Eur J Clin Pharmacol. 2003 Apr;58(12):813-20. doi: 10.1007/s00228-003-0559-5. Epub 2003 Mar 6. Eur J Clin Pharmacol. 2003. PMID: 12698308
-
[Cyclosporine monitoring in patients with chronic uveitis].Ophthalmologe. 2005 Apr;102(4):349-54. doi: 10.1007/s00347-005-1174-x. Ophthalmologe. 2005. PMID: 15726383 Clinical Trial. German.
-
Population pharmacokinetic model to predict steady-state exposure to once-daily cyclosporin microemulsion in renal transplant recipients.Clin Pharmacokinet. 2002;41(1):59-69. doi: 10.2165/00003088-200241010-00005. Clin Pharmacokinet. 2002. PMID: 11825097 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous